Knorr-Bremse – Unsponsored ADR (OTCMKTS:KNRRY – Get Free Report) was the target of a large decrease in short interest in October. As of October 15th, there was short interest totaling 797 shares, a decrease of 87.3% from the September 30th total of 6,287 shares. Based on an average daily volume of 74,149 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.
Knorr-Bremse Stock Up 0.7%
OTCMKTS:KNRRY opened at $26.97 on Tuesday. Knorr-Bremse has a 52 week low of $22.62 and a 52 week high of $33.96. The stock has a market capitalization of $17.39 billion, a PE ratio of 25.27, a price-to-earnings-growth ratio of 0.88 and a beta of 0.38. The stock’s 50-day moving average price is $29.08 and its 200-day moving average price is $29.55.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on KNRRY shares. Citigroup reaffirmed a “buy” rating on shares of Knorr-Bremse in a research note on Tuesday, July 7th. Zacks Research cut shares of Knorr-Bremse from a “hold” rating to a “strong sell” rating in a research note on Wednesday, September 30th. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold”.
View Our Latest Stock Report on KNRRY
Knorr-Bremse Company Profile
Knorr-Bremse AG is a Germany-based manufacturer of braking and other safety-critical systems for rail vehicles and commercial vehicles. The company supplies equipment to original equipment manufacturers and operators, with products designed to support vehicle control, safety, efficiency and passenger or driver comfort.
Its rail vehicle business offers braking systems, doors, entrance systems, climate-control equipment, automatic couplers, digital solutions and other components for trains, metros, trams and locomotives.
See Also
- Five stocks we like better than Knorr-Bremse
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Knorr-Bremse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knorr-Bremse and related companies with MarketBeat.com's FREE daily email newsletter.
